Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells (original) (raw)

Oncogene volume 16, pages 265–272 (1998)Cite this article

Abstract

We constructed an adenoviral vector containing human p16 cDNA in order to evaluate the cytotoxic effects of exogenous p16 expression on cancer cell proliferation and to explore the potential use of p16 in cancer gene therapy. Following infection of human breast (MCF-7, MDA-MB-231, and BT549), osteosarcoma (U-2 OS and Saos-2), cervical (C33a), and lung cancer (H358) cell lines with the recombinant adenovirus Adp16, high levels of p16 expression were observed in all cell lines. Cancer cell lines which were mutant or null for p16 but wild-type for the retinoblastoma gene product (pRb) (MCF-7, MDA-MB-231, BT549 and U-2 OS) were 7 – 22-fold more sensitive to the cytotoxic effects of Adp16 than to a control virus. In contrast, cancer cell lines which were wild-type for p16 but mutant or null for pRb (Saos-2, C33a and H358) were <threefold more sensitive to Adp16 when compared to a control virus. Analysis of 5-bromodeoxyuridine incorporation into DNA following infection with Adp16 showed a loss of S phase in those cell lines which were null or mutant for p16 but expressed a functional pRb. This cell cycle arrest was associated with binding of the p16 protein to cyclin-dependent kinase 4 and dephosphorylation of pRb. In contrast, human cancer cell lines expressing a wild-type p16 and a mutant pRb or no pRb showed no substantial loss of S phase following Adp16 infection. Based on these studies, we conclude that p16-mediated cytotoxicity is tightly associated with the presence of functional pRb in human cancer cells, and that tumor cells which are mutant or null for p16 are candidates for Adp16 mediated cancer gene therapy.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Author notes

  1. Caroline Craig and Min Kim: CC and MK made equal contribution

Authors and Affiliations

  1. Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland
    Caroline Craig, Min Kim, Ekta Ohri, Dai Katayose, Zhuangwu Li, Yung Hyun Choi, Bali Mudahar, Prem Seth & Kenneth Cowan
  2. Pathology Branch, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland
    Robert Wersto
  3. Surgery Branch, USUHS, Bethesda, 20814, Maryland, USA
    Shiv Srivastava

Authors

  1. Caroline Craig
    You can also search for this author inPubMed Google Scholar
  2. Min Kim
    You can also search for this author inPubMed Google Scholar
  3. Ekta Ohri
    You can also search for this author inPubMed Google Scholar
  4. Robert Wersto
    You can also search for this author inPubMed Google Scholar
  5. Dai Katayose
    You can also search for this author inPubMed Google Scholar
  6. Zhuangwu Li
    You can also search for this author inPubMed Google Scholar
  7. Yung Hyun Choi
    You can also search for this author inPubMed Google Scholar
  8. Bali Mudahar
    You can also search for this author inPubMed Google Scholar
  9. Shiv Srivastava
    You can also search for this author inPubMed Google Scholar
  10. Prem Seth
    You can also search for this author inPubMed Google Scholar
  11. Kenneth Cowan
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Craig, C., Kim, M., Ohri, E. et al. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.Oncogene 16, 265–272 (1998). https://doi.org/10.1038/sj.onc.1201493

Download citation

Keywords